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Abstract
Current care guidelines recommend glucose control (GC) in
critically ill patients. To achieve GC, many ICUs have implemented a
(nurse-based) protocol on paper. However, such protocols are
often complex, time-consuming, and can cause iatrogenic hypogly-
caemia. Computerized glucose regulation protocols may improve
patient safety, efficiency, and nurse compliance. Such computerized
clinical decision support systems (CDSSs) use more complex logic
to provide an insulin infusion rate based on previous blood glucose
levels and other parameters. A computerized CDSS for glucose
control has the potential to reduce overall workload, reduce the
chance of human cognitive failure, and improve glucose control.
Several computer-assisted glucose regulation programs have been
published recently. In order of increasing complexity, the three main
types of algorithms used are computerized flowcharts, Proportional-
Integral-Derivative (PID), and Model Predictive Control (MPC). PID
is essentially a closed-loop feedback system, whereas MPC models
the behaviour of glucose and insulin in ICU patients. Although the
best approach has not yet been determined, it should be noted that
PID controllers are generally thought to be more robust than MPC
systems. The computerized CDSSs that are most likely to emerge
are those that are fully a part of the routine workflow, use patient-
specific characteristics and apply variable sampling intervals.
Introduction
There is widespread consensus [1] that hyperglycaemia
should be treated with insulin in patients in the ICU, although
appropriate glucose levels achieved through glucose control
(GC) are still under debate. Insulin therapy in ICU patients,
even with a moderate glucose target range, is complex and
time consuming, particularly since insulin-induced severe
hypoglycaemia should be avoided. In most ICUs, protocols
for GC are paper-based and nurse-driven. However, even
with this form of standardization medication errors frequently
occur and play a major part in overall patient safety, which is
a key issue in all healthcare systems. For safety and
efficiency, computerized clinical decision support systems
(CDSSs) appear to be superior to standard paper protocols.
Patient data management systems and computerized
physician order entries are increasingly being used in the
ICU, both with and without decision support. This review
focuses on the progressively more complex approaches that
have recently been introduced to achieve GC. Successful
implementation of computer-guided GC is of relevance to
other ICU domains, since the basic titration principle behind
GC (for example, increase insulin infusion if glucose is high)
holds for numerous other clinical ICU problems. Although this
is not a formal exhaustive review, this paper discusses several
important studies on paper protocols and development of
computer assisted methods, including flowcharts,
Proportional-Integral-Derivative (PID) and Model Predictive
Controllers (MPC).
Glucose control with paper protocols
Hyperglycaemia frequently occurs in critically ill patients and
is strongly associated with adverse outcome in patients with
acute myocardial infarction [2], stroke [3], and trauma [4,5].
Also in a heterogeneous ICU population hyperglycaemia was
associated with increased hospital mortality [6,7]. This
observation raised the interesting question of whether
normalizing blood glucose (BG) improves outcome. In 2001
van den Berghe and colleagues [8] showed a one-third
mortality reduction in surgical ICU patients treated with
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intensive insulin therapy (using a paper protocol for insulin
infusion). However, subsequent high-quality controlled trials
[9-11] and a large cohort study [12] in both medical and
surgical ICU patients could not replicate this mortality benefit.
The recently published international NICE-SUGAR (Normo-
glycaemia in Intensive Care Evaluation - Survival Using
Algorithm Regulation) trial [13] demonstrated in 6,104
patients that ‘tight’ GC with a target of 4.5 to 6.0 mmol/L was
associated with a higher mortality. The investigators used a
computer-assisted glucose regulation protocol. In the meta-
analysis that followed (including the NICE-SUGAR study
data), no mortality benefit was demonstrated in the tight
glycemic control group [14]. However, because there is con-
sensus about avoiding serious hyperglycaemia, GC in ICU
patients is still recommended so that glucose levels should
be kept at approximately <8.0 mmol/L [1,13].
To achieve desired glucose levels, insulin therapy is required
in most ICU patients. GC requires intensive monitoring of
glucose levels with frequent adjustments of insulin therapy. A
first step in managing GC is the use of protocols that allow
physicians and nurses to decide unambiguously how much
insulin should be administered. The recommendations of
these protocols are generally based on previous glucose
levels and insulin dosing according to a ‘sliding scale’
protocol (a predetermined amount of insulin is administered
according to the actual BG) or ‘dynamic’ protocol (the
dosage of insulin is changed by a certain amount, according
to the actual BG) [15]. Given the frequency of BG sampling,
it rapidly became apparent that the nurses who care for the
patient should have a central role in executing GC.
Standardizing GC by a nurse-managed protocol has been
found to improve safety and efficiency of GC [16].
Hypoglycaemia
One of the main challenges in achieving glycaemic control is
minimizing the risk of hypoglycaemia. Hypoglycaemia can
cause serious complications and should be prevented in
critically ill patients [17]. In several studies an increased
occurrence of severe hypoglycaemia was strongly associated
with tight glycemic control. Two large trials investigating the
clinical effects of strict GC that were prematurely ended
showed high rates of iatrogenic hypoglycaemia [10,11].
Although the overall evidence suggests that the beneficial
effects of insulin therapy may outweigh the possible negative
effects of hypoglycaemia [18], fatalities occurring due to
iatrogenic hypoglycaemia are not acceptable. A balance must
be struck between the preferred level of control and the
number of measurements. To achieve GC with a low incidence
of hypoglycaemia without excessive BG sampling, more
complex computer supported algorithms are required that
manage the patients with an increased risk for hypoglycemia.
Introduction of computerized glucose control
For many years, computer software has been recognized as a
promising tool to improve clinical practice as many adverse
events can be traced back to preventable human errors.
These so-called CDSSs are information systems designed to
improve clinical decision making using characteristics of the
individual patient. Implementations of these systems have
been shown to reduce serious medication errors [19] and
improve adherence to recommended care [20]. In the past
few years several computer directed glucose regulation
programs have been investigated for their effectiveness and
safety in critically ill patients. We performed a literature
search (PubMed, Cochrane and Medline) to find published
computer-based intravenous insulin protocols that were
designed for critically ill patients and tested in an ICU setting
(in at least 15 patients). Table 1 summarizes the 19 identified
studies [13,21-38].
How to create artificial control?
Devising an algorithm for controlling blood glucose is a
challenging task. The algorithm should be evaluated to be
safe, robust and efficient for a population of patients with a
wide range of clinical conditions. To date, three types of
algorithms have been considered for BG regulation:
(heuristic) paper-based or equivalent computerized flow-
charts, PID and MPC.
Computerized flowcharts
The first flow-chart protocol was based on studies by van den
Berghe and colleagues [8,9]. It allows nurses to determine (at
the bedside) the necessary adjustment of the insulin pump
based on the most recent BG value and the trend (using the
number and levels of past BG values to determine the trend).
In case of extremely low BG or other exceptional cases,
special actions are planned. The paper-based flow-chart
protocol can easily be converted into a computerized form
(see, for example, Thomas and colleagues [36] and Laha and
colleagues [28]). Furthermore, the use of computers allows
an increase in the sensitivity (resolution) of the titration part,
for example, in the Vanderbilt protocol [21]. The formula uses
a simple multiplier, which is determined and adjusted
according to previous BGs (BG in mmol/L; multiply multiplier
by 18 for BG in mg/dl):
Insulin dose (U/h) = Multiplier × (BG – 3.3) (Equation 1)
where the multiplier is adjusted by 0.01 up or down when two
consecutive BGs are above 6.1 or below 4.4 mmol/L, respec-
tively; in the case of extreme values (<3.3 or >11 mmol/L) the
multiplier is adjusted by 0.02, and in the case of BG <3.3, the
insulin dose becomes zero. Boord and colleagues [21], and
later Dortch and colleagues [24], demonstrated an
improvement in overall GC compared to a previous manual
protocol. At the same time, a glucose sample was required
approximately 18 times per day.
PID control
A titration formula like Equation 1 puts the control algorithm in
the class of the so-called PID controllers. These are the mostAvailable online http://ccforum.com/content/13/5/223
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.widely used controllers in industrial applications. Typical
examples are the kitchen furnace and automotive cruise
control. The basic idea of PID control is easy to explain:
deviation of the controlled quantity (BG in our case) from the
target is corrected by adapting the control parameter (insulin)
using a linear combination of absolute deviation, trend, and the
sum of past deviations. In fact, a PID controller has already
been used in the BioStator, the first device for ‘glucose
clamping’, developed in the late 1970s [39]. Equation 1
utilizes only the proportional (P) part of the PID control.
Vogelzang and colleagues [38,40] also use the derivative (D)
component. For the rationale behind the application of the
integral (I) part, see Wintergerst and colleagues [41].
Model predictive controllers
A great deal of work has been invested in mathematical
modelling of glucose regulation. Models of various complexi-
ties have been constructed in the past 50 years, as recently
comprehensively reviewed by Chee and Fernando [42].
Deterministic mathematical models can also serve as a basis
for the development of control algorithms. Given the model
equations and the values of all model parameters, one is able,
in principle, to precisely compute the glucose evolution in
response to any insulin infusion strategy. In theory, this allows
a selection of an optimal insulin infusion scenario. In practice,
however, mathematical models rarely exactly describe reality,
and a large number of parameters need to be estimated, which
will inevitably lead to errors in prediction of glucose response.
An example of such complex MPC was developed by the
CLINICIP (Closed Loop Insulin Infusion in Critically Ill
Patients) group. The ultimate goal is a closed loop system for
glycemic control. Plank and colleagues [32] describe, in a
multicenter randomized controlled trial, glucose management
with the MPC program in 30 patients after cardiac surgery.
Compared with routine protocols for glucose regulation, the
time within target range improved significantly (19% to 52%)
during the first 24 hours postoperatively. However, an hourly
glucose sample was necessary, which substantially increased
the workload of the ICU nursing staff. Thereafter, the
algorithm was enhanced with a variable sampling interval
based on the accuracy of the glucose prediction. The
improved protocol (eMPC) resulted in a 50% drop in
sampling frequency [31] and maintained effective glucose
control in different ICUs, with different (nutritional) protocols
and during cardiac surgery [22,26]. The authors report that
the program was safe in 30 patients. It should be noted,
however, that the published incidence of hypoglycaemia, a
key safety indicator, varies from less than 1% to a few
percent, thus rendering a sample size too small to assess
such a safety parameter.
PID versus MPC
The following might serve as a caricature explanation of the
difference between PID and MPC. Suppose a person wants
to drive a car on a mountain road. The control (equivalent to
the art of driving) consists of two continuous inputs: steering
and throttle. The PID approach would be analogous to a
driver negotiating the road by continuously adjusting the input
parameters, correcting deviation from the ideal line,
proceeding along as the new corners or obstacles appear in
front. The MPC strategy would be analogous to studying the
whole road and selecting the driving strategy before the
departure. Note that even the MPC approach does not
guarantee 100% success as the strategy might have to be
adjusted to changing conditions like rain, other road users,
and so on. This example is illustrated in Figure 1.
The theoretical advantage of the MPC over the PID approach
is that the ‘intelligent’ control algorithm could be able to
minimize glucose oscillations and keep glucose within the
target range better than PID controllers. This, however, would
require further improvement of not only the mathematical
models and the parameter estimation procedures, but the
control algorithms as well, since the current results of in silico
(that is, with a virtual electronic patient) testing exhibit rather
dramatic oscillatory behavior [43].
Finally, some believe that with the envisioned introduction of
continuous glucose monitoring systems (CGMSs) in the ICU
setting, the current problem - high workload for nurses
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Figure 1
Model Predictive Control (MPC) versus Proportional-Integrate-
Derivative (PID) control. When using MPC control, the driver
determines (‘calculates’) his driving strategy before departure after
careful investigation of the road. When he uses the correct information
(input variables), he stays on the road (yellow car), but small errors in
input variables can lead the car in the wrong direction (red and blue
cars). The drivers using PID control readjust their driving strategy often
by frequently calculating the difference with the ‘ideal’ track.resulting from frequent glucose measurements - will reduce
considerably. Results reported in the literature strongly
suggest that, with the frequent sampling of BG, the more
transparent PID controllers are fully capable of regulating
glucose successfully. However, application of CGMSs in the
ICU setting is still hampered by a relative inaccuracy of the
existing sensors. Moreover, it must be noted that regardless
of the algorithm employed, CGMSs may not come so easily
or cheaply as originally envisioned, since the devices are
expensive and may require quite frequent BG samples as
well, albeit only for calibration purposes. For more discussion
on the combination of CGMSs and PID controllers or PID
control versus MPC control see [44-48].
Computer versus paper-based insulin
infusion protocols
Whether computer-based or paper-based, the underlying
algorithm is the crucial ‘know-how’ responsible for overall
performance. The same algorithm in paper or computer form
should have the same overall performance, provided that
nurses are easily able to use both versions and comply with
recommendations in the same way. Computer implemen-
tations probably offer higher comfort to the nursing staff. The
chance of human error grows dramatically with the complexity
of the protocol when it is implemented on paper. Therefore,
the class of all protocols potentially implementable by
humans is strictly smaller than the class of protocols
implementable on the computer.
Successful implementation of decision
support systems
To make the implementation of a computerized CDSS
successful, the algorithm used is not the only element that
must be taken into account. Kawamoto [49] performed a
systematic review to identify features critical to the success
of a CDSS and concluded that to make a program likely to
succeed, it must be fully part of the caregivers’ routine
workflow and provide the decision support at the time and
location of the actual decision making. Also transparency,
such as documentation of the reasons behind the decision
making, and a feedback mechanism (for example, an alarm as
a reminder for when a glucose sample is required) were
features leading to success. Before implementation, ade-
quate training of the nursing staff and physicians is important.
To date, no systematic studies on the costs of computerized
protocols have been published, but it is likely that a program
that requires 18 measurements per day will turn out to be
more expensive than one that requires 6 measurements per
day.
Future perspectives
To improve patient safety, more and more technology will
arise in healthcare, especially in the ICU, where the
complexity of patient care is high. A system that is effective,
safe, transparent and easy to work with has a chance to
become routine practice. An advantage of computerized
regulation is that improvements of the internal algorithm may
enable a higher level of control and safety while maintaining a
simple user interface. To date there have been no direct
comparisons made between different algorithms, so the best
approach has not been determined yet. Development of a
closed-loop system using continuous BG measurements has
been ongoing for many years. For the near future, the method
of choice for insulin therapy will still be based on intermittent
glucose sampling because the continuous techniques are not
yet reliable enough (mainly in the hypoglycaemic area) and
are expensive.
Conclusion
Computer-assisted glycemic control has proven to be more
safe and effective than paper protocols in ICU patients. A
successful system is nurse-centered, fully integrated into the
routine workflow, transparent, and uses patient-specific
information with intermittent glucose measurements and
variant sampling intervals.
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